NewsBenzinga웨드부시, 아커스 바이오사이언스에 대한 ‘시장수익률 상회’ 의견 재확인···목표주가 43달러 유지 웨드부시, 아커스 바이오사이언스에 대한 ‘시장수익률 상회’ 의견 재확인···목표주가 43달러 유지 Benzinga 2026.09.30 12:25 (GMT+0) Open on Benzinga Other news Citi: AI Boom Weakens US Stocks' Sensitivity to Rising Rates, S&P 500 Valuation Already Above Fair Range Micron Just Broke Support, So Buy MUU Into Strength (NASDAQ:MU) NatWest Group: Margin For Error Is Lower Than Expected (NYSE:NWG) Over 8,000 BTC flowed into CEX platforms on net over the past 7 days, with Binance seeing inflows of over 6,000 BTC Joe Kent Slams Defense Contractors After Lockheed CEO Says Iran War Demand Is ‘Permanent:’ ‘Stop Spilling American Blood for Profit’ Tennant: An Overvalued Dividend King Facing Margin Pressures (NYSE:TNC)
Citi: AI Boom Weakens US Stocks' Sensitivity to Rising Rates, S&P 500 Valuation Already Above Fair Range
Over 8,000 BTC flowed into CEX platforms on net over the past 7 days, with Binance seeing inflows of over 6,000 BTC
Joe Kent Slams Defense Contractors After Lockheed CEO Says Iran War Demand Is ‘Permanent:’ ‘Stop Spilling American Blood for Profit’
